Amicus Therapeutics Stock Forecast
Explanation to Bollinger's Bands
Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.
Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.
Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation
BandWidth defines the current width of the band.
%b defines the current position within the band.
BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)
Live Samples:
Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.
Source: http://www.bollingerbands.com
Amicus Therapeutics stock price down 2.09% on Thursday
(Updated on Apr 18, 2024)
The Amicus Therapeutics stock price fell by -2.09% on the last day (Thursday, 18th Apr 2024) from $10.55 to $10.33. It has now fallen 7 days in a row. During the last trading day the stock fluctuated 2.62% from a day low at $10.32 to a day high of $10.59. The price has fallen in 8 of the last 10 days and is down by -9.86% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -796 thousand shares and in total, 2 million shares were bought and sold for approximately $16.99 million.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -15.67% during the next 3 months and, with a 90% probability hold a price between $8.20 and $10.46 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
FOLD Signals & Forecast
There are few to no technical positive signals at the moment. The Amicus Therapeutics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $10.75 and $11.73. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, February 15, 2024, and so far it has fallen -26.21%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Support, Risk & Stop-loss for Amicus Therapeutics stock
There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.270 between high and low, or 2.62%. For the last week, the stock has had daily average volatility of 2.68%.
Amicus Therapeutics is oversold on RSI14 (20). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (FOLD) For The Upcoming Trading Day Of Friday 19th
For the upcoming trading day on Friday, 19th we expect Amicus Therapeutics to open at $10.41, and during the day (based on 14 day Average True Range), to move between $9.95 and $10.71, which gives a possible trading interval of +/-$0.377 (+/-3.65%) up or down from last closing price. If Amicus Therapeutics takes out the full calculated possible swing range there will be an estimated 7.31% move between the lowest and the highest trading price during the day.
With no support below and resistance from accumulated volume @ $11.48, some $1.15 (11.13%) from the current price of $10.33, our system finds the risk reward not very attractive.
Is Amicus Therapeutics stock A Buy?
Amicus Therapeutics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
Current score: -4.861 Sell Candidate Unchanged
Predicted Opening Price for Amicus Therapeutics of Friday, April 19, 2024
| Fair opening price April 19, 2024 | Current price |
|---|---|
| $10.41 ( 0.81%) | $10.33 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for FOLD
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 10.68 | 3.42 % | |
| R2 | 10.58 | 2.42 % | ||
| R1 | 10.52 | 1.81 % | ||
| Current price: | 10.33 | |||
| Support | S1 | 10.31 | -0.192 % | |
| S2 | 10.25 | -0.81 % | ||
| S3 | 10.14 | -1.81 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 12.43 | 20.33 % | |
| R2 | 12.29 | 18.97 % | ||
| R1 | 11.48 | 11.13 % | ||
| Current price | 10.33 | |||
| Support | S1 | 0 | . | |
| S2 | 0 | . | ||
| S3 | 0 | . |
FAQ
Click here for our free guide on how to buy Amicus Therapeutics Stock.
